about
3D Imaging of Nanoparticle Distribution in Biological Tissue by Laser-Induced Breakdown SpectroscopyLaser spectrometry for multi-elemental imaging of biological tissues.Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.A recombinant fungal lectin for labeling truncated glycans on human cancer cellsCorrigendum: Laser spectrometry for multi-elemental imaging of biological tissues.Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.The multiple roles of amphiregulin in human cancer.Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer propertiesInsulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.Identification of a novel complex BRAF mutation associated with major clinical response to vemurafenib in a patient with metastatic melanoma.Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: influence of ATS/ERS/IASLC guidelines.Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopy.Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI.Access to molecular guided therapy for Langerhans cell histiocytosis patients.Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.The increasing role of amphiregulin in non-small cell lung cancer.[Mechanisms of resistance to anti-BRAF treatments].Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivativesUnusual increased beta-globulins in an elderly patientEfficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma[Elemental imaging using laser-induced breakdown spectroscopy: latest medical applications]The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivoWater-Soluble Aza-BODIPYs: Biocompatible Organic Dyes for High Contrast In Vivo NIR-II ImagingDevelopment of digital PCR molecular tests for clinical practice: principles, practical implementation and recommendationsGold nanoclusters as a contrast agent for image-guided surgery of head and neck tumors
P50
Q28596080-9AE3D449-8028-49EB-BA78-3352B01BA265Q28654458-84632B6D-D4BC-4AC9-9195-42E447B6D1FFQ33731181-F19DE96B-1DF8-484F-8346-D7828CA3A6E1Q35652684-5D6BFA6C-3267-4FD8-A735-A42F34A035EFQ35996635-41DEFFFD-864A-422A-8FEE-88662129903CQ37413127-35FCF233-AA34-4B62-BD20-BDE3502C751FQ37887106-13C578A6-7289-4C82-8D03-B2C79C2CC01EQ39292740-D26E5531-0088-4695-AE5C-EC57CA07D155Q41580211-2FA0312B-731B-429D-B6BB-B9EE4F844AE6Q43807392-001F3619-094D-4DC9-802E-533A7AECF49BQ44193651-F6374D7B-0FC8-4DE5-85ED-B76C43FF066FQ44244420-45C5EADA-0F77-4014-AD41-B9E5EE24C4E2Q45895901-F6FDEF75-CC49-4E1C-8653-5E184832B64EQ48283743-3823C543-EC60-4912-B303-B11962C5E1B4Q50112298-D8DFA036-5A88-4196-9B1E-EAD0C0C5DCF7Q54264787-3D16B541-BA61-4507-A06C-80E9EBED55E5Q54329660-0565AE66-2D2C-43CD-8DCD-52F595AC5770Q54423334-202D2532-0E4C-46F1-892A-4990E21FCF97Q54781921-2DB90D06-B826-41C7-BC4B-76E5845E9BB0Q55069805-3396DC41-F8D4-48F3-B176-05C3770EF72BQ58868507-3242230F-EB83-47E2-89BA-0A50B9F2EC73Q84464250-228582BB-B8D7-4660-94D9-34710B0EE4D4Q88202976-AF0F5559-6DE6-4289-A57B-515BA18BA3BBQ90159245-DE2789AC-78E2-4D6E-A91B-507D66F93A1BQ90359415-F2765F48-01D4-4DE7-9FC1-620EC06BFCB5Q90756078-007B12E1-CEC3-4A60-AFAB-6193A96AD087Q91503069-EC9581FB-F8A5-4F57-B8BD-16FBC7ECC921Q92136453-D412649E-B147-4532-A0E1-13D345B8D3B8
P50
description
researcher ORCID ID = 0000-0002-9425-1577
@en
wetenschapper
@nl
name
Benoit Busser
@ast
Benoit Busser
@en
Benoit Busser
@es
Benoit Busser
@nl
type
label
Benoit Busser
@ast
Benoit Busser
@en
Benoit Busser
@es
Benoit Busser
@nl
prefLabel
Benoit Busser
@ast
Benoit Busser
@en
Benoit Busser
@es
Benoit Busser
@nl
P1153
25824572400
P31
P496
0000-0002-9425-1577